Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
BOSTON, April 08, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company…
Month: April 2021
22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
Another key indicator and milestone of the Increasing Importance of Reducing Cigarette Nicotine Content as…
NTG Nordic Transport Group A/S – Annual General Meeting 2021
Company announcement no 14 – 218 April 2021 NTG Nordic Transport Group A/S – Annual…
Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform
NEW YORK, NY, and REHOVAT, ISRAEL, April 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical,…
Last Chance for Children is Proud to Announce its Partnership with Generex Biotechnology & NuGenerex Immuno-Oncology to SAFELY and EFFECTIVELY Vaccinate Children and Pregnant Women
NEW YORK, April 08, 2021 (GLOBE NEWSWIRE) — Last Chance for Children’s (LCFC) Mission is…
Golden Leaf Holdings Completes Eighty Percent Acquisition of Plant-Based CBD Skincare Brand, Fifth & Root
PORTLAND, Ore., April 08, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden…
Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy
APX3330 has the Potential to be a Novel Oral Treatment Option with Dual Mechanism of Anti-VEGF…
Vir Biotechnology Announces New Research Demonstrating Novel Mechanisms by Which SARS-CoV-2 Enters Host Cells
– Growing body of evidence suggests monoclonal antibodies that target a conserved epitope have the potential…
Medolife Rx Announces Positive Pre-Clinical Results Showing Up to 95 Percent Cancer Cell Apoptosis with Introduction of Lead Cancer Drug Candidate
BURBANK, Calif., April 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
Mereo BioPharma to Present at the 20th Annual Needham Virtual Healthcare Conference
LONDON and REDWOOD City, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc…
Ceapro Inc. Announces Successful Completion of Collaborative Research and Development Program with University of Alberta
– Project significantly advances broadening the application and utility of Ceapro’s proprietary, first-in-class technologies to…
Auris Medical to Provide Business Update on AM-301 Program on Tuesday, April 13, 2021
Hamilton, Bermuda, April 8, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company…
Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage biopharmaceutical…
Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer
Fast Track designation opens the potential for expedited development and review with the US FDA…
Scout Bio to Present at 20th Annual Needham & Co Virtual Healthcare Conference
PHILADELPHIA, April 08, 2021 (GLOBE NEWSWIRE) — Scout Bio today announced that Mark Heffernan, Chief…
Decibel Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
BOSTON, April 08, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
Connect Biopharma Completes Enrollment of CBP-201 Global Phase 2 Clinical Trial in Moderate-to-Severe Atopic Dermatitis
SAN DIEGO and TAICANG, China, April 08, 2021 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited…
Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program
PHILADELPHIA, April 08, 2021 (GLOBE NEWSWIRE) — Context Therapeutics, a clinical-stage women’s oncology company developing…
Zogenix to Participate in the 20th Annual Needham Virtual Healthcare Conference
EMERYVILLE, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company…
Avadel to Present New Data from its Pivotal REST-ON Phase 3 Study of FT218 at the American Academy of Neurology Annual Meeting 2021
DUBLIN, Ireland, April 08, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…